Skip to main content
CAPR logo
CAPR
(NASDAQ)
Capricor Therapeutics, Inc.
$32.11-- (--)
Loading... - Market loading

Capricor Therapeutics (CAPR) Stock Price & Financial Analysis

Capricor Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.91 - $32.40
52-Week High$40.37
52-Week Low$4.30
Open$29.09
Volume1.22M
Average Volume (3M)1.22M
Market Cap1.47B
Shares Outstanding45.72M
Price to Sales (P/S)123.71
Price to Book (P/B)16.42
EV/EBITDA-16.16
Revenue (TTM)11.13M
Net Income (TTM)-81.99M
Free Cash Flow (TTM)-68.38M
EPS (TTM)$-1.79
Profit Margin-736.62%
Operating Margin-778.80%
Return on Equity (ROE)-97.76%
Debt to Equity0.17
50-Day MA$27.08
200-Day MA$15.33
52-Week Change217.89%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Capricor Therapeutics

What is the current stock price for CAPR?

As of the latest trading session, CAPR stock trades at $32.11. The 52-week range is $4.30–$40.37, with a day range of $28.91–$32.40.

What is the P/E ratio for CAPR?

The P/E ratio (Price-to-Earnings) for CAPR is shown in the Key Statistics section. This valuation metric helps compare Capricor Therapeutics, Inc. to industry peers.

Does CAPR pay dividends?

Capricor Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CAPR?

Based on 3 analysts, the consensus for CAPR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CAPR?

Capricor Therapeutics's market capitalization is $1.47B, classifying it as a small-cap company. Capricor Therapeutics operates in the Healthcare sector within the Biotechnology industry.